• Inspire Announces Results From AZASITE Phase 2 Blephar...
  From Business Wire
  Inspire Pharmaceuticals, Inc. announced today the results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blephar... (Read more)
• Congress Plans Vote on Final Reform Legislation
  From Medpage Today
  Speaker of the House Nancy Pelosi (D-Calif.) rallied her troops this week, preparing for a vote on the healthcare bill, which could mean final passage before President Ob... (Read more)
• Essilor Acquires FGX International, seller of reading g...
  From PR Hub
  Essilor International has acquired FGX International Holdings Limited, the North American market leader in the design and sale of non-prescription reading glasses. The tr... (Read more)
• Roche’s Avastin Fails to Meet Goal of Prostate Study
  From Bloomberg
  Roche Holding AG said its Avastin cancer medicine failed to extend the life of men with late-stage prostate cancer in a study, limiting the Swiss drugmaker’s... (Read more)
• Optometrists could do some surgery under W.Va. bill
  From Amednews.com
  Organized medicine is opposing a West Virginia bill that would allow optometrists to perform surgical procedures, including laser surgery to treat glaucoma, and to order ... (Read more)

Subscribe to EyewireToday.com